Font Size: a A A
Keyword [Partitioned survival model]
Result: 1 - 2 | Page: 1 of 1
1. Value Evaluation Of Pembrolizumab As A Single Agent In The First-line Treatment Of Advanced Non-small Cell Lung Cancer
2. Pharmaco-economic Evaluation Of Sintilimab For First-line Treatment Of Advanced Non-small Cell Lung Cancer
  <<First  <Prev  Next>  Last>>  Jump to